Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
448 pending office actions • 274 clients • 380 examiners • 137 art units • 0 of 448 (0%) have an AI response strategy ready
COOLEY LLP maintains a presence in the Biotechnology & Pharmaceuticals technology area, with 22207 career applications. The firm has achieved a resolved allowance rate of 78.43 percent across this portfolio, reflecting its experience in navigating life sciences patent law. This historical volume provides a data set for understanding the firm's long-term prosecution outcomes.
The firm is currently managing 331 pending office actions, indicating the volume of active prosecution work. On average, the firm receives 3.53 office actions per allowance. This average of 3.53 serves as an indicator of the typical examination cycle for the firm's filings. With 22207 career applications and 331 pending office actions, the firm demonstrates scale and engagement in the Biotechnology & Pharmaceuticals sector. These metrics are used for evaluating the firm's capacity and performance in the pharmaceutical field. The 78.43 percent allowance rate benchmarks the firm's historical success.
Based on the USPTO statutory response window for each pending office action. 117 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 117 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 11 (2%) |
| §101 + other | 40 (9%) |
| §103 only | 94 (21%) |
| §102 only | 19 (4%) |
| §112 only | 32 (7%) |
| Double-patenting only | 15 (3%) |
| Double-patenting + other | 84 (19%) |
| Multi-statute (no §101) | 148 (33%) |
| No statute on record | 5 (1%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOERNER, PAUL ELLSWORTH | 3 | 50.6% | +62.3% |
| HAGHIGHATIAN, MINA | 3 | 46.0% | +39.4% |
| COLEMAN, BRENDA LIBBY | 3 | 74.8% | +15.7% |
| WEDDINGTON, KEVIN E | 3 | 75.2% | +9.8% |
| TU, AURELIE H | 3 | 56.4% | +60.3% |
| HEASLEY, MEGHAN CHRISTINE | 3 | 75.2% | +34.0% |
| DEKARSKE, MADELINE MCGUIRE | 3 | 0.0% | +0.0% |
| RODRIGUEZ, RAYNA B | 3 | 33.6% | +19.2% |
| LIU, SUE XU | 3 | 20.9% | +18.6% |
| KIM, YUNSOO | 3 | 65.9% | +34.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17944127 | INTRA-AORTIC BALLOON PUMP ASSEMBLY | GHAND, JENNIFER LEIGH-STEWAR | 119d overdue |
| 18021323 | LFA-1 SIGNALLING MEDIATOR FOR USE IN CANCER THERAPY | HOPKINS, SAMANTHA LAKE | 110d overdue |
| 17491079 | SYSTEMS, DEVICES, AND METHODS FOR NON-INVASIVE CARDIAC MONITORING | XU, JUSTIN | 100d overdue |
| 17019042 | SYSTEMS, DEVICES, AND METHODS FOR FORMING AN ANASTOMOSIS | DELLA, JAYMI E | 100d overdue |
| 19175765 | BODILY-FLUID TRANSFER SYSTEM FOR BODILY FLUID SAMPLING | PATEL, OM | 91d overdue |
| 18407010 | FLUID CONTROL DEVICES AND METHODS OF USING THE SAME | TU, AURELIE H | 85d overdue |
| 17723112 | CLEAN SCREEN CONTACTLESS ANALYTE DETECTION TEST | GLOVER, NELSON ALEXANDER | 84d overdue |
| 17203464 | CONNECTION QUALITY ASSESSMENT FOR EEG ELECTRODE ARRAYS | PORTER, JR, GARY A | 81d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18407010 | FLUID CONTROL DEVICES AND METHODS OF USING THE SAME | TU, AURELIE H | 85d overdue |
| 17083078 | SYSTEMS AND METHODS FOR PROCESSING SONIFIED BRAIN SIGNALS | TU, AURELIE H | 79d overdue |
| 17914308 | BISMUTH THIOL COMPOUNDS AND COMPOSITIONS AND METHODS OF TREATING MICROBIAL CO-INFECTIONS | HAGHIGHATIAN, MINA | 31d overdue |
| 17802927 | METHODS AND COMPOSITIONS FOR PREVENTING ADSORPTION OF THERAPEUTIC PROTEINS TO DRUG DELIVERY SYSTEM COMPONENTS | KIM, YUNSOO | 18d overdue |
| 18581000 | NOVEL COMPOUNDS AND USES THEREOF | COLEMAN, BRENDA LIBBY | 5d |
| 19023132 | FORMULATIONS OF PSILOCIN THAT HAVE ENHANCED STABILITY | HOERNER, PAUL ELLSWORTH | — |
| 19023120 | FORMULATIONS OF PSILOCIN THAT HAVE ENHANCED STABILITY | HOERNER, PAUL ELLSWORTH | — |
| 19016588 | METHODS AND COMPOSITIONS FOR ALTERING SECONDARY METABOLITES IN PLANTS | HAGHIGHATIAN, MINA | — |
| Art Unit | Apps |
|---|---|
| 3791 | 15 |
| 1628 | 11 |
| 1641 | 10 |
| 3794 | 9 |
| 3771 | 9 |
| 1627 | 9 |
| 3796 | 8 |
| 3792 | 7 |
| 1643 | 7 |
| 1626 | 7 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19538898 | INJECTABLE HYDROGEL | Allegro NV | GOTFREDSON, GAREN | 1619 | §102§103§112Other | Non-Final OA | — | Pending | Feb 12, 2026 |
| 19445099 | MULTI-SENSOR PATCH AND SIGNAL ANALYZER THAT ENABLE SAFE CARDIAC ABLATION | Field Medical, Inc. | VAHDAT, KHADIJEH A | 3794 | §103§112 | Final Rejection | — | Pending | Jan 09, 2026 |
| 19444133 | TISSUE ABLATION CATHETER WITH AN INSULATOR BETWEEN INNER AND OUTER ELECTRODES | Field Medical, Inc. | OUYANG, BO | 3794 | §103 | Final Rejection | — | Pending | Jan 08, 2026 |
| 19431012 | SALT FORMS OF R-MDMA AND METHODS USING THE SAME | Empathbio, Inc. | MOU, LIYUAN | 1628 | §103§112DP | Final Rejection | — | Pending | Dec 23, 2025 |
| 19429313 | SYSTEMS, DEVICES, AND METHODS FOR REDUCING HEART VALVE REGURGITATION | Nyra Medical, Inc. | MANNAN, MIKAIL A | 3774 | §102§103§112Other | Non-Final OA | — | Pending | Dec 22, 2025 |
| 19420125 | NATUREMOUNT SOLAR ARRAYS | 1St Avenue Nova, LLC | SUN, MICHAEL Y | 1728 | §102§103§112 | Non-Final OA | — | Pending | Dec 15, 2025 |
| 19413886 | PHARMACEUTICAL COMPOSITIONS FOR DELIVERY TO THE EYE | Astellas US LLC | SHIN, DANA H | 1635 | §102§112DP | Non-Final OA | — | Pending | Dec 09, 2025 |
| 19409031 | EPIGENETIC EDITING TOOL FOR TARGETING HEPATITIS B VIRUS GENE | Epigenic Therapeutics Pte. Ltd. | SHIN, DANA H | 1635 | §112Other | Final Rejection | — | Pending | Dec 04, 2025 |
| 19399418 | SYSTEMS, DEVICES, AND METHODS FOR CONTROLLING ACTUATION OF TISSUE RESECTION DEVICES | Prana Thoracic, Inc. | RHODES, NORA W | 3794 | §103 | Non-Final OA | — | Pending | Nov 24, 2025 |
| 19393433 | MINIMALLY INVASIVE NASAL TURBINATE SURGERY | Spirair, Inc. | HOLWERDA, KATHLEEN SONNETT | 3771 | §102§103 | Final Rejection | — | Pending | Nov 18, 2025 |
| 19392021 | COMPOSITIONS AND METHODS FOR TREATING GENETIC DISORDERS | Fundación Para La Investigación Biomédica Del Hospital Infantil Universitario Niño Jesús | POPA, ILEANA | 1633 | §103 | Final Rejection | — | Pending | Nov 17, 2025 |
| 19383352 | METHOD FOR GENERATING IMMUNOREGULATORY CELLS IN A BLOOD-DERIVED SAMPLE | Therakos Development Limited | HAMA, JOANNE | 1647 | §103DP | Non-Final OA | — | Pending | Nov 07, 2025 |
| 19379098 | METHODS AND APPARATUS FOR IMPLEMENTING DATA ACCESS WITHIN A FILESYSTEM ACROSS CONTROL PLANES AND DATA PLANES | Domino Data Lab, Inc. | HAILU, TESHOME | 2434 | §103 | Non-Final OA | — | Pending | Nov 04, 2025 |
| 19374441 | METHODS AND SYSTEMS FOR FACILITATING OXYGEN-ENRICHED PARTIAL OXIDATION REACTIONS TO CONVERT HYDROCARBONS INTO CARBON MONOXIDE AND HYDROGEN | Emvolon, Inc. | ANTHONY, JOSEPH DAVID | 1764 | §103§112 | Non-Final OA | — | Pending | Oct 30, 2025 |
| 19334242 | METHODS FOR DEPLOYMENT OF AN IMPLANT | Zenflow, Inc. | GANESAN, SUBA | 3774 | §103 | Non-Final OA | 15d | Pending | Sep 19, 2025 |
| 19320650 | ELECTROLYTE INCLUDING ELECTROLYTE SOLVENT, FLUOROETHER, AND BIS(FLUOROSULFONYL) SALT, AND LITHIUM METAL ELECTROCHEMICAL CELLS INCLUDING THE SAME | 24M Technologies, Inc. | CULLEN, SEAN P | 1725 | §102 | Final Rejection | 60d overdue | Pending | Sep 05, 2025 |
| 19305298 | APPARATUS AND METHOD FOR MEASURING AND APPLYING HIGH VOLTAGE THROUGH A MATRIX OF WIRES AND CONDUCTIVE ELEMENTS | Cardionxt, Inc. | RHODES, NORA W | 3794 | §102§103 | Non-Final OA | 18d overdue | Pending | Aug 20, 2025 |
| 19300138 | SYSTEMS AND METHODS FOR DELIVERY OF A SUBSTERNAL LEAD OF AN IMPLANTABLE DEVICE | North American EP Technology LLC | LAUER, CHRISTINA C | 3771 | §103 | Final Rejection | — | Pending | Aug 14, 2025 |
| 19300364 | SURGICAL ROBOTICS SYSTEMS AND DEVICES HAVING MODIFIED SPEED CONTROL NEAR WORKSPACE BOUNDARIES AND SURFACES, AND METHODS THEREOF | Distalmotion SA | MANCHO, RONNIE M | §102 | Non-Final OA | — | Pending | Aug 14, 2025 | |
| 19300150 | SYSTEMS, DEVICES, AND METHODS FOR HEALTH MONITORING VIA IMPLANTABLE DEVICES IN THE ANTERIOR MEDIASTINUM | North American EP Technology LLC | LOPEZ, SEVERO ANTON P | 3791 | §101§103DP | Final Rejection | — | Pending | Aug 14, 2025 |
| 19290146 | MICRONEEDLE ARRAY SYSTEMS AND DEVICES, AND METHODS ASSOCIATED WITH MANUFACTURING AND USE | Panther Life Sciences Corporation | EPPERT, LUCY CLARE | 3791 | §103 | Final Rejection | 12d | Pending | Aug 04, 2025 |
| 19285497 | CIRCUITS AND METHODS TO HARVEST ENERGY FROM TRANSIENT ON-CHIP DATA | Metis Microsystems, LLC | LAM, TUAN THIEU | 2836 | §101 | Non-Final OA | — | Pending | Jul 30, 2025 |
| 19275299 | IMMOBILIZED ENZYMES FOR THE BIOELECTRIC PRODUCTION OF HYDROGEN PEROXIDE | Anodyne Chemistries, Inc. | SAIDHA, TEKCHAND | 1652 | §102§112DP | Final Rejection | 10d overdue | Pending | Jul 21, 2025 |
| 19243836 | SUBCUTANEOUS FCRN ANTAGONIST FORMULATIONS AND METHODS OF USE THEREOF | Argenx BV | SULLIVAN, DENNIS JOHN | 1642 | §103 | Non-Final OA | 28d | Pending | Jun 20, 2025 |
| 19242555 | METHODS AND APPARATUS FOR MACHINE LEARNING BASED MALWARE DETECTION | Invincea, Inc. | HOFFMAN, BRANDON S | §102Other | Non-Final OA | — | Pending | Jun 18, 2025 | |
| 19234140 | DEVICES, SYSTEMS, AND METHODS FOR MANIPULATING NASAL TISSUES | Spirair, Inc. | LOUIS, RICHARD G | 3771 | §103Other | Non-Final OA | — | Pending | Jun 10, 2025 |
| 19228396 | SYSTEMS, DEVICES AND METHODS FOR HEALTH MONITORING AND IDENTIFICATION OF USERS | Casana Care, Inc. | BARR, MARY EVANGELINE | 3683 | §102§103 | Non-Final OA | — | Pending | Jun 04, 2025 |
| 19213905 | APPARATUSES FOR PULSED ELECTRIC FIELD ABLATION THERAPY INCLUDING EXPANDABLE ELECTRODES, AND SYSTEMS AND METHODS THEREOF | Alpfa Medical, Inc. | HUPCZEY, JR, RONALD JAMES | 3794 | §102§103 | Final Rejection | — | Pending | May 20, 2025 |
| 19210844 | APPARATUS AND METHOD FOR PROCESSING VEHICLE SIGNALS TO COMPUTE A BEHAVIORAL HAZARD MEASURE | Streetscope, Inc. | REDHEAD JR., ASHLEY L | §102 | Final Rejection | — | Pending | May 16, 2025 | |
| 19204207 | WIRELESS INITIATION DEVICE | Orica International Pte. Ltd. | EGOAVIL, GUILLERMO J | §112 | Non-Final OA | — | Pending | May 09, 2025 | |
| 19196106 | ANTIGEN VARIANT OF VARICELLA ZOSTER VIRUS AND USE THEREOF | Mogam Institute For Biomedical Research | DRISCOLL, LORA E BARNHART | 3991 | §103§112DP | Non-Final OA | — | Pending | May 01, 2025 |
| 19193799 | DEVICES AND METHODS FOR TISSUE REMOVAL AND WOUND CLOSURE | Osheru, Inc. | LABRANCHE, BROOKE N | §102§103 | Non-Final OA | — | Pending | Apr 29, 2025 | |
| 19191923 | TRANSCATHETER DELIVERABLE PROSTHETIC HEART VALVES AND METHODS OF DELIVERY | VDyne, Inc. | YABUT, DIANE D | §102§103DP | Non-Final OA | — | Pending | Apr 28, 2025 | |
| 19123383 | Methods for Suppression of Gene Silencing in Plants | Biodrive, Inc. | KRUSE, DAVID H | §102§103§112 | Non-Final OA | — | Pending | Apr 22, 2025 | |
| 19181114 | SYSTEM AND METHOD FOR GENERATING A MULTI-COMPONENT SIGNAL INCLUDING A MODULATED SIGNAL AND AN AUXILIARY SIGNAL | Terawave, Inc. | KASSA, ZEWDU A | §103 | Non-Final OA | — | Pending | Apr 16, 2025 | |
| 19181139 | METHOD FOR EMBEDDING MESSAGE WAVEFORMS WITHIN CONVENTIONALLY MODULATED SIGNALS | Terawave, Inc. | SALTARELLI, DOMINIC D | §102§103Other | Non-Final OA | — | Pending | Apr 16, 2025 | |
| 19178636 | METHODS AND APPARATUS FOR ESTIMATING DEPTH INFORMATION FROM THERMAL IMAGES | Rivet Industries, Inc. | SUMMERS, GEOFFREY E | 2669 | §112 | Final Rejection | 1d overdue | Pending | Apr 14, 2025 |
| 19177229 | APPARATUSES, SYSTEMS, AND METHODS FOR PROCESSING OF THREE DIMENSIONAL OPTICAL MICROSCOPY IMAGE DATA | Alpenglow Biosciences, Inc. | RIDER, JUSTIN W | 2486 | §103 | Non-Final OA | — | Pending | Apr 11, 2025 |
| 19175765 | BODILY-FLUID TRANSFER SYSTEM FOR BODILY FLUID SAMPLING | Magnolia Medical Technologies, Inc. | PATEL, OM | 3791 | §103§112 | Non-Final OA | 91d overdue | Pending | Apr 10, 2025 |
| 19171122 | SYSTEM AND METHOD FOR AUTOMATIC ANALYSIS OF TEXTS IN PSYCHOTHERAPY, COUNSELING, AND OTHER MENTAL HEALTH MANAGEMENT ACTIVITIES | Mind Medicine, Inc. | LANE, DANIEL E | 3715 | §101§102§112 | Non-Final OA | — | Pending | Apr 04, 2025 |
| 19098339 | METHOD FOR COMMUNICATION OVER TIME-BASED CHANNELS | Terawave, Inc. | PEREZ, JAMES M | §112 | Non-Final OA | — | Pending | Apr 02, 2025 | |
| 19098805 | SYSTEMS AND METHODS FOR SEIZURE DETECTION | Ceribell, Inc. | MCCORMACK, ERIN KATHLEEN | 3792 | §101§103§112 | Non-Final OA | — | Pending | Apr 02, 2025 |
| 19088669 | APPARATUS AND METHOD FOR A NEURAL INTERFACE UTILIZING SENSORY COMMUNICATION TO AFFECT A BROAD SPECTRUM OF PHYSIOLOGIC ACTIVITY IN THE HUMAN BODY | Synapcis Inc. | TRAN, JENNY NGAN | §101§103§112 | Non-Final OA | — | Pending | Mar 24, 2025 | |
| 19084221 | SYSTEMS AND METHODS FOR ANALYZING, INTERPRETING, AND ACTING ON CONTINUOUS GLUCOSE MONITORING DATA | Welldoc, Inc. | BLOCH, MICHAEL RYAN | DP | Non-Final OA | — | Pending | Mar 19, 2025 | |
| 19080483 | SYSTEMS AND METHODS FOR DETECTING FOODBORNE PATHOGENS USING SPECTRAL ANALYSIS | Hyperspectral Corp. | KIDWELL, KAITLYN ELIZABETH | §101§103 | Non-Final OA | — | Pending | Mar 14, 2025 | |
| 19076444 | APPARATUS AND METHOD FOR CONDUCTING ENDPOINT-NETWORK-MONITORING | Huntress Labs Incorporated | GRACIA, GARY S | §103 | Non-Final OA | — | Pending | Mar 11, 2025 | |
| 19075437 | METHODS AND APPARATUS FOR MOBILE DEVICE MESSAGING-BASED COMMUNICATIONS USING CUSTOM-GENERATED DEEPLINKS AND BASED ON THE HYPER TEXT TRANSFER PROTOCOL (HTTP) | Attentive Mobile Inc. | UBALE, GAUTAM | 3689 | §101§103Other | Non-Final OA | — | Pending | Mar 10, 2025 |
| 19069820 | TWIN-CONFIGURABLE ARCHITECTURE RENEWABLE POWER PLANT FOR HIGH-CAPACITY FACTOR SERVICING OF CONTROLLABLE LOADS | 1St Avenue Nova, LLC | PEREZ BORROTO, ALFONSO | 2836 | §112Other | Final Rejection | 139d overdue | Pending | Mar 04, 2025 |
| 19069118 | APPARATUS AND METHOD FOR TREATING NEUROLOGICAL DISORDERS | Newronika S.p.A. | ROANE, AARON F | §101§102Other | Non-Final OA | — | Pending | Mar 03, 2025 | |
| 19065984 | ONE-OPERATOR SURGICAL SYSTEM AND METHODS OF USE | Levita Magnetics International Corp. | GHIMIRE, SHANKAR RAJ | 3795 | §102§103 | Non-Final OA | — | Pending | Feb 27, 2025 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial78.4% of resolved applications prosecuted by Cooley LLP were allowed, across 22,207 applications in USPTO records.
3.53 office actions per allowed application on average.
448 pending office actions as of October 2026, for 274 clients, before 380 examiners in 137 art units.